Exploratory Efficacy Results from the TANDEM Trial: Safety, Tolerability, and Efficacy of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine (P8-12.002)
Year: 2025
Type: article
Source: Neurology
Authors: Andrew M. Blumenfeld, Molly Yizeng He, Jonathan H. Smith, Casey Schlacher, Janette Contreras-De Lama, Linda Davis
Institution: AbbVie (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409226295